US Stock MarketDetailed Quotes

Eloxx Pharmaceuticals (ELOX)

Watchlist
  • 0.1300
  • 0.00000.00%
15min DelayClose Apr 22 15:46 ET
659.35KMarket Cap-0.27P/E (TTM)

Eloxx Pharmaceuticals (ELOX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
6.36M
0
0
0
0
0
0
0
0
Operating revenue
--0
--6.36M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.06%6.44M
-48.94%8.83M
-49.77%17.29M
-33.18%4.03M
-49.08%3.64M
-59.79%4.14M
-49.94%5.48M
-47.86%34.42M
-48.17%6.03M
-30.29%7.14M
Selling and administrative expenses
-35.58%3.38M
-39.59%5.25M
-18.72%8.69M
-8.24%2.51M
5.53%2.39M
-31.87%1.8M
-34.68%2M
-47.71%10.69M
-26.55%2.73M
-55.07%2.26M
-General and administrative expense
-35.58%3.38M
-39.59%5.25M
-18.72%8.69M
-8.24%2.51M
5.53%2.39M
-31.87%1.8M
-34.68%2M
-47.71%10.69M
-26.55%2.73M
-55.07%2.26M
Research and development costs
-14.57%3.06M
-58.40%3.58M
-63.76%8.6M
-53.84%1.52M
-74.39%1.25M
-69.44%2.34M
-55.84%3.49M
-47.93%23.73M
-58.33%3.3M
-6.33%4.88M
Operating profit
-160.86%-6.44M
85.72%-2.47M
49.77%-17.29M
33.18%-4.03M
49.08%-3.64M
59.79%-4.14M
49.94%-5.48M
47.86%-34.42M
48.17%-6.03M
30.29%-7.14M
Net non-operating interest income expense
22.83%-862K
-24.25%-1.12M
46.33%-899K
55.91%-194K
43.57%-215K
59.86%-173K
18.72%-317K
-33.89%-1.68M
9.09%-440K
-102.66%-381K
Non-operating interest income
22.22%33K
-89.29%27K
-8.03%252K
-95.04%7K
-81.48%20K
147.83%57K
1,100.00%168K
3,325.00%274K
603.57%141K
200.00%108K
Non-operating interest expense
-8.30%1.05M
-0.61%1.14M
-40.94%1.15M
-65.40%201K
-51.94%235K
-49.34%230K
20.05%485K
54.81%1.95M
27.41%581K
118.30%489K
Total other finance cost
---154K
----
----
----
----
----
----
----
----
----
Other net income (expense)
195.25%1.31M
-60.99%442K
3,806.90%1.13M
793.29%1.33M
1,633.33%260K
-125.69%-28K
-55.23%-430K
-94.65%29K
520.83%149K
-97.26%15K
Gain on sale of security
-74.73%95K
-75.63%376K
3,314.58%1.54M
1,779.17%1.35M
1,566.67%250K
-132.14%-36K
91.34%-24K
-2,500.00%-48K
200.00%72K
87.50%15K
Special income (charges)
9,415.38%1.24M
108.78%13K
---148K
--3K
--255K
--0
---406K
--0
--0
--0
-Less:Other special charges
-5,044.00%-1.24M
-94.27%25K
--436K
--30K
----
----
--406K
----
----
----
-Gain on sale of property,plant,equipment
-97.37%1K
-86.81%38K
--288K
--33K
--255K
----
----
----
----
--0
Other non- operating income (expenses)
-150.94%-27K
120.23%53K
-440.26%-262K
---25K
---245K
366.67%8K
----
--77K
----
----
Income before tax
-90.74%-6M
81.57%-3.14M
52.71%-17.05M
54.25%-2.89M
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
Income tax
Net income
-90.74%-6M
81.57%-3.14M
52.71%-17.05M
54.25%-2.89M
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
Net income continuous Operations
-90.74%-6M
81.57%-3.14M
52.71%-17.05M
54.25%-2.89M
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
Minority interest income
Net income attributable to the parent company
-90.74%-6M
81.57%-3.14M
52.71%-17.05M
54.25%-2.89M
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-90.74%-6M
81.57%-3.14M
52.71%-17.05M
54.25%-2.89M
52.16%-3.59M
59.12%-4.34M
46.39%-6.23M
45.95%-36.07M
47.73%-6.32M
24.05%-7.51M
Basic earnings per share
41.67%-0.49
87.33%-0.84
60.18%-6.63
77.05%-0.67
62.25%-1.31
60.00%-1.96
46.27%-2.88
56.36%-16.65
47.86%-2.92
21.14%-3.47
Diluted earnings per share
41.67%-0.49
87.33%-0.84
60.18%-6.63
77.05%-0.67
62.25%-1.31
60.00%-1.96
46.27%-2.88
56.36%-16.65
47.86%-2.92
21.14%-3.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 06.36M00000000
Operating revenue --0--6.36M--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.06%6.44M-48.94%8.83M-49.77%17.29M-33.18%4.03M-49.08%3.64M-59.79%4.14M-49.94%5.48M-47.86%34.42M-48.17%6.03M-30.29%7.14M
Selling and administrative expenses -35.58%3.38M-39.59%5.25M-18.72%8.69M-8.24%2.51M5.53%2.39M-31.87%1.8M-34.68%2M-47.71%10.69M-26.55%2.73M-55.07%2.26M
-General and administrative expense -35.58%3.38M-39.59%5.25M-18.72%8.69M-8.24%2.51M5.53%2.39M-31.87%1.8M-34.68%2M-47.71%10.69M-26.55%2.73M-55.07%2.26M
Research and development costs -14.57%3.06M-58.40%3.58M-63.76%8.6M-53.84%1.52M-74.39%1.25M-69.44%2.34M-55.84%3.49M-47.93%23.73M-58.33%3.3M-6.33%4.88M
Operating profit -160.86%-6.44M85.72%-2.47M49.77%-17.29M33.18%-4.03M49.08%-3.64M59.79%-4.14M49.94%-5.48M47.86%-34.42M48.17%-6.03M30.29%-7.14M
Net non-operating interest income expense 22.83%-862K-24.25%-1.12M46.33%-899K55.91%-194K43.57%-215K59.86%-173K18.72%-317K-33.89%-1.68M9.09%-440K-102.66%-381K
Non-operating interest income 22.22%33K-89.29%27K-8.03%252K-95.04%7K-81.48%20K147.83%57K1,100.00%168K3,325.00%274K603.57%141K200.00%108K
Non-operating interest expense -8.30%1.05M-0.61%1.14M-40.94%1.15M-65.40%201K-51.94%235K-49.34%230K20.05%485K54.81%1.95M27.41%581K118.30%489K
Total other finance cost ---154K------------------------------------
Other net income (expense) 195.25%1.31M-60.99%442K3,806.90%1.13M793.29%1.33M1,633.33%260K-125.69%-28K-55.23%-430K-94.65%29K520.83%149K-97.26%15K
Gain on sale of security -74.73%95K-75.63%376K3,314.58%1.54M1,779.17%1.35M1,566.67%250K-132.14%-36K91.34%-24K-2,500.00%-48K200.00%72K87.50%15K
Special income (charges) 9,415.38%1.24M108.78%13K---148K--3K--255K--0---406K--0--0--0
-Less:Other special charges -5,044.00%-1.24M-94.27%25K--436K--30K----------406K------------
-Gain on sale of property,plant,equipment -97.37%1K-86.81%38K--288K--33K--255K------------------0
Other non- operating income (expenses) -150.94%-27K120.23%53K-440.26%-262K---25K---245K366.67%8K------77K--------
Income before tax -90.74%-6M81.57%-3.14M52.71%-17.05M54.25%-2.89M52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M
Income tax
Net income -90.74%-6M81.57%-3.14M52.71%-17.05M54.25%-2.89M52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M
Net income continuous Operations -90.74%-6M81.57%-3.14M52.71%-17.05M54.25%-2.89M52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M
Minority interest income
Net income attributable to the parent company -90.74%-6M81.57%-3.14M52.71%-17.05M54.25%-2.89M52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -90.74%-6M81.57%-3.14M52.71%-17.05M54.25%-2.89M52.16%-3.59M59.12%-4.34M46.39%-6.23M45.95%-36.07M47.73%-6.32M24.05%-7.51M
Basic earnings per share 41.67%-0.4987.33%-0.8460.18%-6.6377.05%-0.6762.25%-1.3160.00%-1.9646.27%-2.8856.36%-16.6547.86%-2.9221.14%-3.47
Diluted earnings per share 41.67%-0.4987.33%-0.8460.18%-6.6377.05%-0.6762.25%-1.3160.00%-1.9646.27%-2.8856.36%-16.6547.86%-2.9221.14%-3.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes------------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More